NEW YORK (GenomeWeb News) – The National Cancer Institute said on Monday that it plans to use $10 million to fund new research projects by small businesses that focus on specific high-priority areas where new devices and technologies are needed to support cancer diagnosis and treatment.

Funded under the Small Business Innovation Research (SBIR) program, the new grants will support projects to develop a range of technologies that are based on genomic, proteomic, and metabolomic discoveries, among others.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.